Health, Fitness & Food

Four of our Club holdings — Costco Wholesale (COST), Amazon (AMZN), Humana (HUM) and Bausch Health (BHC) — were in the news Thursday. Here’s how we feel about the developments. Costco The news: Costco reported sales for the retail month of October after the closing bell Wednesday evening. In the four-week period, net sales increased 7.7%

A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, September 8, 2022. Hannah Beier | Reuters Moderna on Thursday lowered its 2022 sales guidance for its Covid-19 vaccine after missing Wall Street expectations for the third quarter. The Boston

Club holding Humana (HUM) reported a mixed-but-solid third quarter before the opening bell Wednesday. Early optimism about 2023 also supported our bullish view on the health insurer’s stock. Revenue increased 9% year-over-year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings-per-share increased 42% to $6.88, exceeding estimates of $6.28 per share. Aiding

Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla laid out his plan Tuesday

Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in a CNBC interview with Jim Cramer. “Seventy percent of our

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Pfizer on Tuesday raised its 2022 earnings guidance after booking a strong third quarter that

A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) at a sport stadium during the coronavirus disease pandemic, in Vina del Mar, Chile, April 22, 2021. Rodrigo Garrido | Reuters Long Covid is more common among women than men, according to federal data. More than 17% of women have had long

There are more than 100,000 people in the United States waiting for an organ transplant, according to the United Network for Organ Sharing, known as UNOS. “I was born Type 1 diabetic,” said Patrick McGlone, who received a dual kidney-pancreas transplant in June 2021. “There was always the word transplant thrown around. But I never

Medical staff treat a coronavirus disease (COVID-19) patient on the Intensive Care Unit (ICU) at the Cleveland Clinic in Cleveland, Ohio, January 7, 2022. Shannon Stapleton | Reuters Emerging omicron subvariants are resistant to key antibody treatments for HIV patients, kidney transplant recipients and other immunocompromised people, making them particularly vulnerable to Covid this winter,

We’re exiting our position in AbbVie (ABBV), selling 300 shares at roughly $148.14 each. We’re also buying 75 shares of Starbucks (SBUX) at roughly $85.93 each. Following Friday’s trades, Jim’s Charitable Trust will no longer own a position in AbbVie and will own 750 shares of Starbucks, increasing its weighting in the portfolio to 2.28%

AbbVie (ABBV) reported a mixed second-quarter Friday morning. Despite a pullback in shares after the release, we decided to lock-in a great 61% return and exit a stock that has been one of this year’s winners. We never like to sell on a down day, but multiple quarters in a row of revenue misses raised our

A pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. The recently authorized booster vaccine protects against the original SARS-CoV-2 virus and the more recent omicron variants, BA.4 and BA.5. Scott Olson |

A rendering of COVID-19 new Omicron sub-variant BQ.1.1 Koto_feja | E+ | Getty Images Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S.,

Covid cases and controls have increased in China this month. Pictured here on Oct. 27, 2022, is a neighborhood in Shanghai that’s been fenced in for Covid control. Future Publishing | Future Publishing | Getty Images BEIJING — Covid controls in China have tightened in the last two weeks after more cities reported virus outbreaks.

The new COVID-19 booster which includes protection for Omicron at AltaMed Health Services in South Gate on Thursday, October 6, 2022. Sarah Reingewirtz | MediaNews Group | Los Angeles Daily News via Getty Images Two studies are raising doubts about whether the new omicron BA.5 booster really will offer better protection against Covid than the

Club holding Humana (HUM) got an upgrade on Wall Street on Wednesday, exactly one week before the health insurer reports earnings. Deutsche Bank took Humana to a buy rating from a hold, citing its “leading position in Medicare Advantage,” a key reason we own the company as a defensive play in this tough economic environment.

Founder and CEO of Maven Clinic Kate Ryder, the first female health tech unicorn, valued at $1 billion. Daniel Zuchnik | Getty Images Entertainment | Getty Images Women account for half of consumers, hold power over 80% of household financial decisions and make 70% of health-care-related decisions in their families – but their access to

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Healthcare and staples leading the market Quick mentions: META, DIS, SBUX 1. Health care and consumer staples leading the market Stocks gained on Monday, with health-care and staples stocks leading

A patient receives a coronavirus disease (COVID-19) test at Sparrow Laboratories Drive-Thru Services in Lansing, Michigan, December 27, 2021. Emily Elconin | Reuters People who caught mild cases of Covid-19 during the first year of the pandemic had a higher risk of developing blood clots than those who were not infected, according to a large

Senator Ted Kennedy (D-MA) boards an elevator after walking off the floor of the U.S. Senate after a roll call vote to achieve cloture on the nomination of Judge Samuel Alito to the US Supreme Court passed 72 to 25 January 30, 2006 in Washington, DC. Chip Somodevilla | Getty Images Supreme Court Justice Samuel